[Dobutamine Enhances the Targeted Inhibitory Effect of Quizartinib on FLT3-ITD Mutant Acute Myeloid Leukemia].
Yu-Ang GaoQian-Yu ZhangXin LiShen-Yu WangJi-Hui LiYang XueChang-Yan LiHong-Mei Ning
Published in: Zhongguo shi yan xue ye xue za zhi (2024)
mutated AML. The mechanism may involve the inhibition of YAP1 protein expression in AML cells of this type, leading to an increase in ROS levels and exerting its anti-tumor effects.